Biomarkers to predict infection and infection-related complications during chemotherapy-induced neutropenia in acute myeloid leukaemia: a pilot study

Br J Haematol. 2021 Jun;193(5):1008-1012. doi: 10.1111/bjh.17422. Epub 2021 Apr 8.

Annemarie van de Geer¹, Judith Zandstra^{2

3}, Michael W T Tanck⁴, Erfan Nur⁵, Gerard van Mierlo², Ilse Jongerius², Robin van Bruggen¹, Sacha S Zeerleder^{2

5

6

7}, Taco W Kuijpers^{1

3}

¹ Department of Blood Cell Research, Division Research and Landsteiner Laboratory of Amsterdam UMC, Sanquin Blood Supply, Amsterdam, the Netherlands.
² Department of Immunopathology, Division Research and Landsteiner Laboratory of Amsterdam UMC, Sanquin Blood Supply, Amsterdam, the Netherlands.
³ Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam UMC, Amsterdam, the Netherlands.
⁴ Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam Public Health (APH), Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
⁵ Department of Hematology, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands.
⁶ Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁷ Department for BioMedical Research, University of Bern, Bern, Switzerland.

No abstract available

Keywords: acute myeloid leukaemia; biomarker; febrile neutropenia.

Publication types